| 1. Celmatix14 Wall Street, Suite 16D New York, NY 10005. Focus on a female’s infertility and women’s health through technology-enabled products and better data. |
| 2. Harlem Biospace 423 W 127th Street New York, NY 10027 Harlem Biospace is a biotech incubator, the first of its kind in New York City that offers a affordable shared wet-lab space for competitively-selected entrants. |
| 3. TARA Biosystems 430 E 29th St New York, NY 10016 Pioneers predictive tissue models that enable development of new medicines for cardiac physiology, as well as can help reduce and potentially eliminate, the use of animals in drug development. |
| 4. Iovance Biotherapeutics 112 W. 34th Street 17th Floor New York, NY 10120 Iovance is focused on the development and commercialization of novel cancer immunotherapies that are based on tumor infiltrating lymphocytes (TIL). |
| 5. Alpha 1 Biologics 25 Health Sciences Drive Suite 100 Stony Brook, NY 11790 The founding of Alpha 1 wasto develop a patented biotechnology related to the generation of immune cells from stem cells within the body to treat immunodeficiency with the following disease applications: Immune cell replenishment (pre- and post-cancer therapy, HIV/AIDS); HDL and LDL regulation (cardiovascular disease); and Diagnostic testing (CD4 enumeration, leukemia) |
| 6. United Biomedical 25 David Drive Hauppauge, NY 11788 Their product pipeline is filled with their new line of synthetic peptide-based biologicals for the treatment and prevention of Alzheimer’s Disease, AIDS, and Allergy, in addition to animal health diseases. |
| 7. Lucerna 760 Parkside Avenue Suite 311 Brooklyn, New York 11226 Company foucses on RNA-based research reagents that enables scientific discovery. |
| 8. Mirimus 760 Parkside Avenue Suite 206 Brooklyn, NY 11226 Mirimus engages in the design, development and pioneering of new genome editing technologies that develop animal models that are crucial for the preclinical evaluation of new therapeutics. The company’s focus is on chemotherapy, with the determination to dramatically improve outcomes for cancer patients. |
| 9. Accutheranostics 875 Ellicott Street Suite 5080 Buffalo, NY 14203 The company’s focus is on chemotherapy, with the determination to dramatically improve outcomes for cancer patients. |
| 10. For-Robin 97 Troyview Lan Williamsville, NY 14221 For-Robin is an antibody immunotherapy company whose central mission is developing treatmens for both breast and lung cancers. |
| 11. A&Z Pharmaceutical, Inc. 350 Wireless Blvd Happauge NY 11788 Taken from the company’s website, “out products encircle life, from newborns to active and aging adults, providing exceptional nutritional value and educational guidance for the well-being of the entire family.” |
| 12. Saptalis 45 Davids Drive, Happauge NY 11788 Specializing in development, manufacturing and commercialization of specialty generic prescription (Rx) and Over-The- Counter (OTC) products. |
| 13. BeyondSpring Pharmaceuticals 28 Liberty Street, 39th Floor, New York, NY 10005 The company’s lead asset, Plinabulin, is in a Phase 3 global clinical trial as a direct anticancer agent in the treatment of non-small cell lung cancer (NSCLC) and two Phase 2/3 clinical programs in the prevention of chemotherapy-induced neutropenia (CIN). |
| 14. Bioharmony Therapeutics 340 east 80th street. Apt 17F, New York, NY 10075 Aim to develop next-gen antimicrobial therapies for lethal multi-drug resistant bacterial infections. |
| 15. Blue Water Vaccines New York, NY Their vaccines protects against all influenza strains. |
| 16. Chimeron 14 Wall Street, Suite 16D, New York, NY 10005. New York, NY 10013 Focus on a female’s chance in fertility and women’s health through technology-enabled products and better data. |
| 17. Elucida Oncology 228 Park Avenue South New York, NY 10003 Clinical research and development is based on the Target or Clear™ technology of our novel, ultra-small nanoparticle delivery platform. |
| 18. ENB Therapeutics 166 Fifth Ave, 2nd flr New York, NY 10010 They are developing small molecule inhibitors of a novel pathway to treat melanoma and other cancers. |
| 19. Envisagenics 101 Avenue of the Americas, 3rd Floor New York, NY 10013 Envisagenics discovers therapeutic points of intervention by finding the right patient population and design RNA therapeutics to treat diseases |
| 20. Epivax Oncology 180 Varick Street, Suite 665 New York, NY 10014 A precision cancer immunotherapy company that is developing mutanome-directed, neo-epitope personalized therapeutic vaccines. |
| 21. Forkhead Biotherapeautics 430 East 29th Street Alexandria LaunchLabs, 14th Floor New York, NY 10016 They aim to harness the intrinsic capabilities of cell conversion and regeneration in order to develop transformative therapies that improve patient’s lives. |
| 22. Kallyope 430 East 29th Street, 10th Floor New York, NY 10016 Specializing in how the gut communicates with the brain. |
| 23. Kantar Health 175 Greenwich Street, 35th Floor New York, NY 10007 A global healthcare consulting and research company that provides decision support for products and services that fall under healthcare |
| 24. Nuerogene 434 W 33rd St New York, NY 10001 They are developing new genetic medicines to people with devastating neurological diseases and their families. |
| 25. Progyny 245 Fifth Avenue New York, NY 10016 Has an optimistic, and somewhat of a wishful thinking approach to their practices, where they strive to achieve the vision they have, which is a world where anyone who wants to have a baby can. |
| 26. Qunetis Therapeautics 430 E 29th St, Suite 1005 New York, NY 1006 Quentis is translating novel biology into new therapeutic approaches to address ER stress in multiple diseases, beginning with their first program in cancer. For example, he company’s first-in-class IRE1α inhibitor is designed to target ER stress pathways and awaken the immune system’s ability to fight cancer. |
| 27. RedPin Therapeutics 101 Sixth Avenue, Third Floor New York, NY 10013 They are a a privately held, preclinical stage gene therapy company that is developing a proprietary chemogenetics platform for targeted cell therapies that address currently intractable diseases of the nervous system. |
| 28. Roar Biomedical 3960 Broadway New York, NY 10032 Roar develops, manufactures, and markets novel fluorescence-based methods. |
| 29. Tactical Therapeutics 48 Wall Street, 12th Floor New York, NY 10005 Tactical is “a privately funded, clinical stage company that has developed and patented a lead therapeutic Carboxyamidotriazole Orotate (CTO)(Pravitinib(TM)) for the orphan indication glioblastoma (GBM) (fewer than 200,000 or 1 in 1500 persons are affected) and for other refractory targets.” |
| 30. ConSynance Therapeautics 5 University Place Rensselaer, NY 12144 ConSynance is a clinical-stage biopharmaceutical company focused on developing innovative therapeutics for serious metabolic diseases. |
| 31. Endo Pharmaceuticals 6 Ram Ridge Road Rye, NY 10977 Endo’s main focus areas are: Endocrinology, Medical Aesthetics, Orthopedics, and Urology & Men’s Health |
| 32. Ampersand Biosciences 3 Main St. Saranac Lake, NY 12983 Ampersand specializes in the development and manufacturing of immunoassay kits. |
| 33. Black Diamond Therapeutics 25 Health Sciences Drive Stony Brook, NY 11790 Pioneers the development of selective medicines for patients with genetically-defined cancers driven by oncogenes that are activated by allosteric mutations. |
| 34. Empire Genomics 1000 Youngs Road, Suite 207 Williamsville, NY 14221 Empire Genomics designs, manufactures and distributes more than one million clinical and custom labeled molecular probes, enabling for which they boast hundreds of leading global clinical laboratories, biotechnology organizations and academic institutions to advance biomarker research, as well as accelerate diagnoses and improve personalized treatment options for patients battling cancer and other complex diseases. |
| 35. Bioarray Genetics 400 Farmington Ave. CB126 R1822 Farmington, CT 06032 Bioarray Genetics began in 2009 by understanding the critical unmet need for patient stratification in treating Triple Negative Breast Cancer (TNBC). |
| 36. Lipid Genomics 400 Farmington Avenue, Suite R1718 Farmington, CT 06032 Their mission is to develop diagnostics and therapeutics targeted at patients with acute and chronic inflammatory diseases, such as acute immunotoxicity in oncology and chronic atherosclerotic heart disease. |
| 37. GestVision 93 Shennecossett Road Groton, NY 06340 Committed to securing safer pregnancies by “fearlessly challenging the status quo for women’s health.” |
| 38. MIFCOR PO Box 484 Riverside, CT 06878 MIFCOR is building on the body’s natural defense mechanisms to develop therapies that reduce tissue damage that’s associated with heart attacks, acute kidney injury, and other indications. |
| 39. Trevi Therapeautics 195 Church Street, 14th Floor New Haven, CT 06510 Trevi is developing nalbuphine ER to treat serious neurologically mediated conditions by targeting the central and peripheral nervous systems. |
| 40. Springworks Therapeautics 100 Washington Blvd Stamford, CT 06902 SpringWorks Therapeutics is a clinical-stage biopharmaceutical company that identifies and advances pathways for drug development for patients with severe rare diseases and cancer. |
Celebrating Women Leading The Business of Life Science Innovation in Metro New York And Beyond
Metropolitan New York Biotech Companies with Female Founders
By Biotech Metropolitan Women7 Mins ReadRelated Posts
Company
Subscribe to Updates
Get the latest news from Biotech Metropolitan Women.
Biotech Metropolitan Women ©2018-2023